Tag: PAXLOVID
Biden tests positive for COVID-19 after Paxlovid course l ABCNL
President Joe Biden tested positive for COVID-19 over the weekend after initially recovering. Dr. Todd Ellerin and ABC News Deputy Political Director Averi Harper break…
Biden experiencing ‘mild symptoms’ after testing positive for COVID-19
ABC News Chief Medical Correspondent Dr. Jen Ashton discusses President Joe Biden testing positive for COVID-19 and why he was given Paxlovid immediately after his…
White House says Biden’s symptoms have improved after 1 day on Paxlovid | ABCNL
ABC News medical contributor and physician at Stanford Children’s Health, Dr. Alok Patel, on what’s to be expected throughout the president’s recovery after he tested…
Learning more about Biden’s COVID-19 recovery | ABCNL
ABC News’ senior national policy reporter Anne Flaherty and Stanford Children’s Health physician Dr. Alok Patel discuss the latest update on President Joe Biden’s COVID…
FDA limits use of J&J COVID vaccines
Following an investigation into reports of rare blood clots, the FDA is restricting access to the vaccine. READ MORE: https://abcn.ws/3P3ch4l #ABCNews #Vaccine #COVID19 #BloodClot source
New COVID outbreak hotspots as cases increase l GMA
The U.S. has seen 997,000 deaths from COVID and will likely cross 1 million within the week as cases rise in hotspots in New York,…
COVID-19 hospitalizations and death expected to rise
The FDA announced a limit on the Johnson & Johnson vaccine to people 18 and older who don’t otherwise have access to a different vaccine….
Dozens of companies set to start manufacturing Pfizer COVID-19 pill l ABC News
The U.N.-backed Medicines Patent Pool says companies will begin making generic versions of the Pfizer pill for low- and middle-income countries. READ MORE: https://abcn.ws/3qibaDg #ABCNews…
FDA authorizes Pfizer’s COVID-19 treatment pill
Pfizer’s Paxlovid is a series of 30 pills that can be taken at home over five days and is shown to reduce the risk of…
Pfizer releases early trial results of COVID-19 pill l GMA
The pharmaceutical company said early trial results of its anti-viral COVID pill, PAXLOVID, reduces risk of being hospitalized or dying by 89%. READ MORE: https://abcn.ws/3EMZz42…